Cancer Genetics, Inc. (CGIX): Price and Financial Metrics

Cancer Genetics, Inc. (CGIX): $4.61

0.11 (-2.33%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

CGIX Price/Volume Stats

Current price $4.61 52-week high $17.50
Prev. close $4.72 52-week low $2.11
Day low $4.30 Volume 612,400
Day high $4.69 Avg. volume 2,437,482
50-day MA $5.46 Dividend yield N/A
200-day MA $3.87 Market Cap 18.83M

CGIX Stock Price Chart Interactive Chart >


Cancer Genetics, Inc. (CGIX) Company Bio


Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor, and inform cancer treatment; and enable biopharmaceutical companies involved in oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. The company was founded in 1999 and is based in Rutherford, New Jersey.


CGIX Latest News Stream


Event/Time News Detail
Loading, please wait...

CGIX Latest Social Stream


Loading social stream, please wait...

View Full CGIX Social Stream

CGIX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year -23.93%
YTD N/A
2023 N/A
2022 N/A
2021 0.00%
2020 -53.52%
2019 -17.22%

Continue Researching CGIX

Want to see what other sources are saying about Cancer Genetics Inc's financials and stock price? Try the links below:

Cancer Genetics Inc (CGIX) Stock Price | Nasdaq
Cancer Genetics Inc (CGIX) Stock Quote, History and News - Yahoo Finance
Cancer Genetics Inc (CGIX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!